Sponsored session - The road to global cervical cancer elimination: The role of multi-stakeholder collaboration in scaling equitable access to prevention, screening & diagnosis

Session co-organised by Cervivor (United States) & Roche Diagnostics International Ltd (Switzerland)

Chaired by Durhane Wong-Rieger, Canadian Organization for Rare Disorders (CORD) (Canada)

Presentations:

1. Panel discussion with:

Sofiat Akinola, Roche Diagnostics International (Switzerland)

H.E. Mrs. Kim Simplis Barrow, Belize Cancer Society (Belize)

Tamika Felder, Cervivor (United States)

Matthias Schuppe, European Commission (Belgium)

Zainab Shinkafi-Bagudu, MEDICAID Cancer Foundation (Nigeria)

Description:

Cervical cancer is one of the most common cancers faced by women worldwide. Still, despite its high prevalence, cervical cancer is largely preventable and treatable if detected early and managed effectively. Women in low-and middle-income countries and women in high-income countries from marginalized groups are disproportionately affected by cervical cancer. They are more likely to be screened and diagnosed late when treatment is more invasive and less effective.

Broad access to early, accurate screening and diagnosis, especially in cancer care, is essential to help people live healthier lives. With the WHO Global Strategy to Accelerate the Elimination of Cervical Cancer, there is renewed opportunity to advocate for equitable access to early prevention measures such as HPV vaccination, screening, and increased momentum to unite stakeholders behind common goals. In this panel session, experts will discuss opportunities for multi-stakeholder collaboration to scale up equitable and sustainable cervical cancer elimination efforts globally.